ENGLEWOOD, Colo., May 19, 2011 /PRNewswire/ -- In response to growing concerns about how to safely administer over-the-counter (OTC) liquid medications to children and the recent FDA Guidance for Industry on OTC delivery devices, Baxa Corporation, the leading provider of oral liquid drug delivery syringes, is available to discuss the following best practices for safe liquid medication administration at home and in hospitals:
- Can the Cup – Calling upon more than 35 years of work with leading pediatric care centers around the world and data from the ISMP (Institute for Safe Medication Practices), Baxa cautions against using dosing cups to administer liquid medication to infants and children.
A February 2010 study of more than 300 parents published in the Archives of Pediatric & Adolescent Medicine found that, when using a dosing cup with printed markings, 70% of parents made mistakes and almost all mistakes involved administering too much medicine.
- Look for OTC medications packaged with oral syringes – Many OTC medications come with cups because they are cheaper to manufacture and easier to package. However, this lower price at the register comes at the expense of safety. Leading hospitals in the United States use oral syringes to safely administer liquid medication to children infants because of their accuracy in dosage and efficiency in administration (including parenteral syringes). ISMP and The Joint Commission, the accrediting body for US hospitals and healthcare providers, both support this best practice.
"When giving my children oral medication, I prefer to measure and administer the medication using a syringe rather than a cup," said Colin Sox, MD, MS, a general pediatrician in Boston. "Oral syringes not only allow for more precise dosage, but also make administering medicine much easier, especially for young children."
- Clearly label and graduate syringes for specific oral medications – Unfortunately, not all dosage delivery devices are clearly labeled to match the exact OTC medication and dosing directions. As a result, mismatches can occur that lead to confusion and dosing errors. Customized liquid dosing devices, rather than generic graduated cups or syringes can dramatically impact patient safety with little incremental cost to drug manufacturers.
According to a recent study published in the Journal of the American Medical Association that evaluated 200 OTC liquid drug products, of the 75% of products that came with a dosage delivery device, 98.6% had at least one mismatch between the device and the written dosing directions.
"The recent Food and Drug Administration guidance for orally ingested OTC liquid drug products is an important wake-up call to the industry and a much-needed rallying cry for parents who rely on drug manufacturers to produce medication that is safe and easy to administer," said Greg Baldwin, CEO of Baxa Corporation. "As the inventor of the first oral syringe in 1975 and an innovator of fluid drug delivery systems, Baxa is committed to providing solutions that advance the safe delivery of all liquid medications and reduce the risk of dosing error."
For more information about Baxa and to download the recent FDA Guidance, please visit: http://www.baxa.com/oem/downloads.html
To schedule an interview with Baxa and for all media inquiries: Related medicine technology :1
Perrin McCormick or Brandie Gerrish
. Verizon Wireless and Medco Unveil First Mobile Medication App with Real-Time Patient-Specific Drug Safety and Savings Information2
. CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication3
. APhA Encourages Seniors to Connect with Their Pharmacist to Increase Wellness and Medication Knowledge4
. Medco Research Institute® and AssureRx Health Initiate Pilot Program to Evaluate Adoption and Clinical Impact of Pharmacogenetic Testing for Selection of Psychotropic Medications5
. Omnicell Unveils Largest Ever Medication and Supply Automation Product Launch: the G4 Platform6
. New Study Finds Individuals Who Adhere to Their Diabetes Medication Have a 31% Associated Lower Risk of Hospitalization7
. Less than One-Third of Patients Taking Montelukast (Singulair®) Therapy for Asthma or Allergies without Trying First-Line Medications End Up Staying on the Medication8
. New Life Agency Adds Watson to Join Walgreens on The Fertility Pharmacy Care Card for Fertility Medication9
. Pharmacists Offer Guidance on Top Over-The-Counter Medications10
. MedVantx and Blue Cross & Blue Shield of Rhode Island Partner to Provide Physicians with Integrated Medication Management Platform in Newly Created Patient-Centered Medical Homes11
. UrgentRx® Launches Innovative Line of Portable Life-Saving Medications Across Iowa